Geninus Inc
KOSDAQ:389030
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Geninus Inc
KOSDAQ:389030
|
KR |
|
Aifeex Nexus Acquisition Corp
NASDAQ:PGAC
|
US |
|
O
|
ODigMa Consultancy Solutions Ltd
NSE:ODIGMA
|
IN |
|
F
|
Fonciere Inea SA
PAR:INEA
|
FR |
|
Q
|
Qualcomm Inc
XETRA:QCI
|
US |
|
P
|
Pommersche Provinzial-Zuckersiederei AG
XBER:PPZ
|
DE |
|
Isetan Mitsukoshi Holdings Ltd
OTC:IMHDF
|
JP |
|
G
|
Granite Construction Inc
F:GRG
|
US |
|
Jiangsu Hagong Intelligent Robot Co Ltd
SZSE:000584
|
CN |
Geninus Inc
GENINUS, Inc. is engaged in the research and development of NGS (Next Generation Sequencing)-based genome analysis technology, development and manufacturing of genome analysis solutions. The company is headquartered in Seoul, Seoul. The company went IPO on 2021-11-08. The firm is engaged in the provision of single cell analysis services, genetic testing for disease prediction for the public, cancer genome analysis solutions based on tissue biopsy and other services. The company is also engaged personal genetic testing, software development, rental business and others.
GENINUS, Inc. is engaged in the research and development of NGS (Next Generation Sequencing)-based genome analysis technology, development and manufacturing of genome analysis solutions. The company is headquartered in Seoul, Seoul. The company went IPO on 2021-11-08. The firm is engaged in the provision of single cell analysis services, genetic testing for disease prediction for the public, cancer genome analysis solutions based on tissue biopsy and other services. The company is also engaged personal genetic testing, software development, rental business and others.
